Jeong Yu Jin, Dunn Masako, Fleming Sophie, Thomas Richard, Howes Dale, Clark Jonathan, Low Tsu-Hui
Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
Central Clinical School, Faculty of Medicine and Health Sciences, the University of Sydney, Sydney, New South Wales, Australia.
ANZ J Surg. 2025 Sep;95(9):1881-1889. doi: 10.1111/ans.70201. Epub 2025 Jun 4.
While several techniques have been established in the field of auricular reconstruction, these methods are often inadequate in restoring aesthetic function for cases involving significant defects of the temporal bone, particularly after a lateral temporal bone resection for malignancy. This case series describes a novel approach of auricular reconstruction using subperiosteal implants (IPS Implants Craniofacial Epithesis, KLS Martin Group, Tuttlingen, Germany) at an Australian tertiary cancer referral centre.
The virtual surgical planning (VSP) process and operative technique for subperiosteal implant-retained auricular prosthetic reconstruction in conjunction with a free flap at our institution is described. A retrospective series of cases performed from November 2023 to July 2024 is presented.
Three patients underwent auricular reconstruction with subperiosteal implants. Indications for reconstruction included basal cell carcinoma of the auricle (n = 1) and squamous cell carcinoma involving the ear canals (n = 2). Each patient received one subperiosteal implant (n = 3 retention posts per implant framework). Reconstruction was undertaken with an anterolateral thigh free flap (n = 2) or a radial forearm free flap with adipofascial extension (n = 1). No surgical complications or implant losses were observed in our cohort. Two patients underwent successful loading of an auricular prosthesis 4 and 7 months postoperatively, and retained a functional prosthesis on follow-up. One patient unfortunately died of distant disease at 9 months before prosthesis could be fabricated.
Our series supports the feasibility of a subperiosteal implant-retained prosthetic auricular reconstruction after a temporal bone resection in the setting of malignancy. It provides opportunity for a reliable and robust aesthetic rehabilitation after oncological resection. Long-term data is required to establish the reliability and long-term quality-of-life outcomes associated with this novel application of this technique.
虽然耳再造领域已经建立了多种技术,但对于涉及颞骨严重缺损的病例,尤其是在因恶性肿瘤进行颞骨外侧切除术后,这些方法往往不足以恢复美学功能。本病例系列描述了在澳大利亚一家三级癌症转诊中心使用骨膜下植入物(IPS植入物颅面修复体,KLS Martin集团,德国图特林根)进行耳再造的新方法。
描述了在我们机构中,结合游离皮瓣进行骨膜下植入物保留的耳假体再造的虚拟手术规划(VSP)过程和手术技术。呈现了2023年11月至2024年7月进行的回顾性病例系列。
三名患者接受了骨膜下植入物耳再造。再造的适应证包括耳廓基底细胞癌(n = 1)和累及耳道的鳞状细胞癌(n = 2)。每名患者接受一个骨膜下植入物(每个植入物框架有n = 3个固定柱)。采用股前外侧游离皮瓣(n = 2)或带脂肪筋膜延伸的桡动脉前臂游离皮瓣(n = 1)进行再造。在我们的队列中未观察到手术并发症或植入物丢失。两名患者在术后4个月和7个月成功佩戴耳假体,并在随访中保留了功能性假体。一名患者不幸在假体制造前9个月死于远处疾病。
我们的系列研究支持在恶性肿瘤背景下颞骨切除术后采用骨膜下植入物保留的假体耳再造的可行性。它为肿瘤切除术后可靠且稳固的美学修复提供了机会。需要长期数据来确定与该技术的这种新应用相关的可靠性和长期生活质量结果。